Literature DB >> 12819530

Prolonged retention of drug resistance mutations and rapid disease progression in the absence of therapy after primary HIV infection.

Kenny C Chan1, Richard A Galli, Julio S Montaner, P Richard Harrigan.   

Abstract

We report two separate, unrelated instances of the transmission of HIV-containing mutations associated with high levels of resistance to protease inhibitors or reverse transcriptase inhibitors. In the absence of antiretroviral drugs, these mutations persisted almost unchanged in the newly infected index cases, whereas most mutations reverted to wild type in the source patients upon discontinuation of therapy. Furthermore, a rapid loss of CD4 cells was observed in the newly infected individuals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12819530     DOI: 10.1097/00002030-200305230-00020

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  7 in total

1.  New superbug or tempest in a teapot?

Authors:  Vicki Brower
Journal:  EMBO Rep       Date:  2005-06       Impact factor: 8.807

2.  Nevirapine resistance by timing of HIV type 1 infection in infants treated with single-dose nevirapine.

Authors:  Mark A Micek; Ana Judith Blanco; Ingrid A Beck; Sandra Dross; Laurinda Matunha; Pablo Montoya; Kristy Seidel; Soren Gantt; Eduardo Matediane; Lilia Jamisse; Stephen Gloyd; Lisa M Frenkel
Journal:  Clin Infect Dis       Date:  2010-05-15       Impact factor: 9.079

3.  Differential persistence of transmitted HIV-1 drug resistance mutation classes.

Authors:  Vivek Jain; Maria C Sucupira; Peter Bacchetti; Wendy Hartogensis; Ricardo S Diaz; Esper G Kallas; Luiz M Janini; Teri Liegler; Christopher D Pilcher; Robert M Grant; Rodrigo Cortes; Steven G Deeks; Frederick M Hecht
Journal:  J Infect Dis       Date:  2011-04-15       Impact factor: 5.226

4.  The Role of Baseline HIV-1 Resistance Testing in Patients with Established Infection.

Authors:  Suk-Yin Chan; Todd Hulgan; Richard T. D'Aquila
Journal:  Curr Infect Dis Rep       Date:  2004-06       Impact factor: 3.725

5.  Transmission of nevirapine-resistant HIV type 1 via breast milk to infants after single-dose nevirapine in Beira, Mozambique.

Authors:  Mark A Micek; Sandra Dross; Ana Judith Blanco; Ingrid A Beck; Laurinda Matunha; Kristy Seidel; Pablo Montoya; Eduardo Matediana; Soren Gantt; Stephen Gloyd; Lisa Frenkel
Journal:  J Infect Dis       Date:  2014-03-04       Impact factor: 5.226

6.  Transmitted human immunodeficiency virus-1 drug resistance in a cohort of men who have sex with men in Belo Horizonte, Brazil--1996-2012.

Authors:  Unaí Tupinambás; Helena Duani; Ana Virgínia Cunha Martins; Agdemir Waleria Aleixo; Dirceu Bartolomeu Greco
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-06       Impact factor: 2.743

7.  Persistence of frequently transmitted drug-resistant HIV-1 variants can be explained by high viral replication capacity.

Authors:  Marieke Pingen; Annemarie M J Wensing; Katrien Fransen; Annelies De Bel; Dorien de Jong; Andy I M Hoepelman; Emmanouil Magiorkinis; Dimitrios Paraskevis; Maja M Lunar; Mario Poljak; Monique Nijhuis; Charles A B Boucher
Journal:  Retrovirology       Date:  2014-11-29       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.